Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM 100

 209.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 232.00
  • 52 Week Low: 100.00
  • Currency: UK Pounds
  • Shares Issued: 157.52m
  • Volume: 59,223
  • Market Cap: 329.22m

CREO Overview

Medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -188800.0% -4319.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 32921.7 617.7
Pr/Book 4.0  
Latest F'cast
Revenue n/a 5230.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-16 n/a (1.87) (5.00)p n/a n/a n/a n/a 0.0%
30-Jun-17 n/a (8.91) (7.31)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (17.58) (10.63)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (13.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.53 (23.02) (14.10)p n/a n/a n/a n/a 0.0%
31-Dec-21 3.26 (25.17) (15.50)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Development loan for plasma sterilising product 02-Jul-2020 07:00 RNS
Result of AGM 24-Jun-2020 10:30 RNS
CE mark for five new devices 15-Jun-2020 07:00 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 209.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 232.00
52 Week Low 100.00
Volume 59,223
Shares Issued 157.52m
Market Cap 329.22m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.55% below the market average26.55% below the market average26.55% below the market average26.55% below the market average26.55% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average
Price Trend
86.73% above the market average86.73% above the market average86.73% above the market average86.73% above the market average86.73% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 03-Jul-2020

Time Volume / Share Price
16:34 10,000 @ 209.00p
16:11 604 @ 208.00p
16:10 2,000 @ 209.74p
14:18 5,000 @ 209.80p
14:03 5,000 @ 208.16p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page